ArticleTechnical innovations & patient support in radiation oncology2025
Custom-made, 3D-printed bolus cap for a case of scalp metastasis: A single-institution study.
Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Correspondence on "Custom-made, 3D-printed bolus cap for a case of scalp metastasis: A single-institution study".Technical innovations & patient support in radiation oncology · 2025Article
- Reply to Correspondence by Kleebayoon and Wiwanitkit.Technical innovations & patient support in radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treating multiple scalp metastasis in patients is challenging due to the large area that needs to be treated and the complex structure of the scalp. Dose coverage with coplanar fields is hard to optimize with the Halcyon machine's three degrees of freedom (3DoF) couch movement. A potential solution is to use a 3D-printed bolus, which can be designed to fit the scalp contour. This covers more area to improve dose delivery, ensuring that the skin receives the necessary radiation dose while protecting organs at risk (OaR's). A total dose of 39 Gy was delivered to a 71-year-old patient in 13 fractions as a total scalp irradiation (TSI) treatment. The Volumetric Modulated Arc Therapy (VMAT) technique employed four full arcs, which covered the planning target volume (PTV) and ensured optimal dose distribution across the treatment area. A 3D-printed bolus was created using a flexible resin for patient comfort and improved positioning as well as dose delivery. 95% of the PTV received 98.85% of the prescribed dose, with a maximum dose of 107.1% and a conformity index (CI) of 0.95. At the six-month follow-up, the patient showed no signs of scalp metastases, confirming the success of the treatment across the entire scalp. The use of the custom-made, 3D-printed bolus contributed significantly to the treatment success. This study marks the first clinical experience with 3D-printed boluses in our country. Our previous validation study demonstrates that a designed 3D-printed bolus, when integrated into the clinical setup, can provide solution for customizing treatment in cases involving superficial tumors that require good dose distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.